Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: A randomized clinical trial

Richard D. Carvajal, Jeffrey A. Sosman, Jorge Fernando Quevedo, Mohammed M. Milhem, Anthony M. Joshua, Ragini R. Kudchadkar, Gerald P. Linette, Thomas F. Gajewski, Jose Lutzky, David H. Lawson, Christopher D. Lao, Patrick J. Flynn, Mark R. Albertini, Takami Sato, Karl Lewis, Austin Doyle, Kristin Ancell, Katherine S. Panageas, Mark Bluth, Cyrus HedvatJoseph Erinjeri, Grazia Ambrosini, Brian Marr, David H. Abramson, Mark Andrew Dickson, Jedd D. Wolchok, Paul B. Chapman, Gary K. Schwartz

Research output: Contribution to journal › Article › peer-review

302 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: A randomized clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences